Clinical Trial Update: Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study comparing twice-daily versus once-daily lamivudine (3TC) and abacavir (ABC) as part of combination ART in HIV-infected childr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine (lamivudine)
• abacavir (abacavir)

Snippet

Sponsor: PENTA Foundation | Conditions: HIV Infection | Phase 1 | Status: COMPLETED